Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors

Nephron - Clinical Practice

Volumn 107, Issue 4, 2008, Pages

  Diskin, Charles J ^a   Stokes, Thomas J ^a   Dansby, Linda M ^a   Radcliff, Lautrec ^a   Carter, Thomas B ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Biofilm formation; Catheter related sepsis; Intravenous iron; Systemic heparin

Indexed keywords

FERRIC HYDROXIDE SUCROSE; HEPARIN; IRON; IRON DEXTRAN; SERUM ALBUMIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ANALYSIS OF VARIANCE; ANTICOAGULATION; ARTICLE; ARTIFICIAL KIDNEY; BIOFILM; CATHETER INFECTION; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFECTION RISK; IRON DEFICIENCY; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; RISK FACTOR; SEPSIS; STATISTICAL SIGNIFICANCE; THROMBOSIS;

ADULT; AGED; ANALYSIS OF VARIANCE; BACTEREMIA; BIOFILMS; CATHETERIZATION, CENTRAL VENOUS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 38049024770     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110032     Document Type: Article

References (25)

1. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB: HC-related bacteremia and outcome of attempted HC salvage in patients undergoing hemodialysis. Ann Intern Med1997;127:275-280.
2. Diskin CJ, Stokes TJ: Efficacy of an attachable silver impregnated subcutaneous cuff for the prevention of catheter-associated infections in patients on chronic maintenance hemodialysis. Nephron 1995;69:357-359.
3. Rosenbaum D, Macrae JM, Djurdjev O, Levin A, Werb R, Kiaii M: Surveillance cultures of tunneled cuffed catheter exit sites in chronic hemodialysis patients are of no benefit. Hemodial Int 2006;10:365-370.
4. Nielsen J, Kolmos HJ, Rosdahl VT: Poor value of surveillance cultures for prediction of septicaemia caused by coagulase-negative staphylococci in patients undergoing haemodialysis with central venous catheters. Scand J Infect Dis 1998;30:569-572.
5. Centers for Disease Control and Prevention (CDC): Update: Delayed onset Pseudomonas fluorescens bloodstream infections after exposure to contaminated heparin flush - Michigan and South Dakota, 2005-2006. MMWR Morb Mortal Wkly Rep 2006;55:961-963.
6. Stewart PS, Costerton JW: Antibiotic resistance of bacteria in biofilms. Lancet 2001;358:135-138. 7 Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G: The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 2003;112:1466-1477.
7. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP: The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998;280:295-298.
8. Shanks RM, Donegan NP, Graber ML, Buckingham SE, Zegans ME, Cheung AL, O'Toole GA: Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 2005;73:4596-4606.
9. Mandolfo S, Borlandelli S, Elli A: Catheter lock solutions: it's time for a change. J Vasc Access 2006;7:99-102.
10. Singh PK, Parsek MR, Greenberg EP, Welsh MJ: A component of innate immunity prevents bacterial biofilm development. Nature 2002;417:552-555.
11. Gulati S, Sahu KM, Avula S, Sharma RK, Ayyagiri A, Pandey CM: Role of vascular access as a risk factor for infections in hemodialysis. Ren Fail 2003;25:967-973.
12. Teehan GS, Bahdouch D, Ruthazer R, Balakrishnan VS, Snydman DR, Jaber BL: Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy. Clin Infect Dis 2004;38:1090-1094.
13. Jean G, Charra B, Chazot C, Vanel T, Terrat JC, Hurot JM, Laurent G: Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias. Nephron 2002;91:399-405.
14. Jean G: Incidence and risk factors for infections from hemodialysis catheters. Nephrologie 2001;22:443-448.
15. Abbott KC, Agodoa LY: Etiology of bacterial septicemia in chronic dialysis patients in the United States. Clin Nephrol 2001;56:124-131.
16. Tokars JI, Light P, Anderson J, Miller ER, Parrish J, Armistead N, Jarvis WR, Gehr T: A prospective study of vascular access infections at seven outpatient hemodialysis centers. Am J Kidney Dis 2001;37:1232-1240.
17. Sengoelge G, Sunder-Plassmann G, Hörl WH: Potential risk for infection and atherosclerosis due to iron therapy. J Ren Nutr. 2005;15:105-110.
18. Massonet C, Pintens V, Merckx R, Anne J, Lammertyn E, Van Eldere J: Effect of iron on the expression of sirR and sitABC in biofilm-associated Staphylococcus epidermidis. BMC Microbiol 2006;6:103.
19. Wang MS, Palmer LB, Schwartz JD, Razatos A: Evaluating protein attraction and adhesion to biomaterials with the atomic force microscope. Langmuir 2004;20:7753-7759.
20. Cacoub P, Thiolieres JM, Alexandre JA, Foglietti MJ, Giraudet P, Godeau P: Protein profile and iron deficiency: value of the study of the albumin-transferrin couple. Rev Méd Interne 1996;17:627-634.
21. Simoes M, Pereira MO, Vieira MJ: Action of a cationic surfactant on the activity and removal of bacterial biofilms formed under different flow regimes. Water Res 2005;39:478-486.
22. Ganz T: Molecular control of iron transport. J Am Soc Nephrol 2007;18:394-400.
23. Kurzeder C, Koppold B, Sauer G, Pabst S, Kreienberg R, Deissler H: CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans. Int J Mol Med 2007;19:325-333.
24. Bishop JR, Crawford BE, Esko JD: Cell surface heparan sulfate promotes replication of Toxoplasma gondii. Infect Immun 2005;73:5395-5401.
25. Gao G, Goldfarb M: Heparin can activate a receptor tyrosine kinase. EMBO J 1995;14:2183-2190.